Amgen Inc.

Healthcare · Drug Manufacturers - General · United States

Last price 466.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 251.94B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascul...